13F
EN

JNJ JOHNSON & JOHNSON

2026Q1 · CUSIP 478160104 · 大型药企 · 行业: 医疗与生物科技

点亮 · 机构加速涌入
持有机构数
4,609
本季增减
+89
广度百分位
前 2%
大机构数
368
大机构增减
-5
机构持仓市值
$416.4B
新建仓
301
清仓
212
过去一季价格动量
-5.4%
Put / Call
55/49

广度历史(34 季度)

2018Q1: Δ-23 · h=2595 2018Q2: Δ-4 · h=2591 2018Q3: Δ-12 · h=2579 2018Q4: Δ+182 · h=2761 2019Q1: Δ-1 · h=2760 2019Q2: Δ-14 · h=2746 2019Q3: Δ-21 · h=2725 2019Q4: Δ+262 · h=2987 2020Q1: Δ-61 · h=2926 2020Q2: Δ+63 · h=2989 2020Q3: Δ-10 · h=2979 2020Q4: Δ+285 · h=3264 2021Q1: Δ+46 · h=3310 2021Q2: Δ+18 · h=3328 2021Q3: Δ-17 · h=3311 2021Q4: Δ+330 · h=3641 2022Q1: Δ+32 · h=3673 2022Q2: Δ-6 · h=3667 2022Q3: Δ-50 · h=3617 2022Q4: Δ+163 · h=3780 2023Q1: Δ-47 · h=3733 2023Q2: Δ+13 · h=3746 2023Q3: Δ-64 · h=3682 2023Q4: Δ+186 · h=3868 2024Q1: Δ-20 · h=3848 2024Q2: Δ-45 · h=3803 2024Q3: Δ+79 · h=3882 2024Q4: Δ+225 · h=4107 2025Q1: Δ+38 · h=4145 2025Q2: Δ-60 · h=4085 2025Q3: Δ+101 · h=4186 2025Q4: Δ+334 · h=4520 2026Q1: Δ+89 · h=4609 2018Q1: holders=2595 2018Q2: holders=2591 2018Q3: holders=2579 2018Q4: holders=2761 2019Q1: holders=2760 2019Q2: holders=2746 2019Q3: holders=2725 2019Q4: holders=2987 2020Q1: holders=2926 2020Q2: holders=2989 2020Q3: holders=2979 2020Q4: holders=3264 2021Q1: holders=3310 2021Q2: holders=3328 2021Q3: holders=3311 2021Q4: holders=3641 2022Q1: holders=3673 2022Q2: holders=3667 2022Q3: holders=3617 2022Q4: holders=3780 2023Q1: holders=3733 2023Q2: holders=3746 2023Q3: holders=3682 2023Q4: holders=3868 2024Q1: holders=3848 2024Q2: holders=3803 2024Q3: holders=3882 2024Q4: holders=4107 2025Q1: holders=4145 2025Q2: holders=4085 2025Q3: holders=4186 2025Q4: holders=4520 2026Q1: holders=4609 -334 -167 +0 +167 +334 232135814840 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 环比增减(柱) 持有机构数(线)

历次点亮与事后表现 共 17 次点亮

持仓期 百分位 其后 1 季收益 其后 2 季收益
2026Q1 前 2%
2025Q4 前 0% -5.4%
2025Q3 前 1% +24.5% +16.2%
2025Q1 前 4% +17.6% +33.0%
2024Q4 前 1% -1.6% +15.7%
2024Q3 前 1% +6.6% +0.2%
2023Q4 前 1% -1.2% +2.8%
2023Q2 前 16% -13.7% -7.0%

期权情绪

Put 机构数
55
环比: +5
Call 机构数
49
环比: -2

查看方法论 →

基本面

PE(TTM)
29.3
EPS(TTM)
$8.63
EPS 同比
-4.0%
营收(TTM)
$96.4B
营收同比
+7.9%
近 4 年季度营收与 EPS
2022-07-03: $20.2B 2022-10-02: $20.0B 2023-01-01: $19.9B 2023-04-02: $20.9B 2023-07-02: $21.5B 2023-10-01: $21.4B 2023-12-31: $21.4B 2024-03-31: $21.4B 2024-06-30: $22.4B 2024-09-29: $22.5B 2024-12-29: $22.5B 2025-03-30: $21.9B 2025-06-29: $23.7B 2025-09-28: $24.0B 2025-12-28: $24.6B 2026-03-29: $24.1B 2022-07-03: EPS 1.80 2022-10-02: EPS 1.68 2023-01-01: EPS 1.33 2023-04-02: EPS -0.03 2023-07-02: EPS 1.96 2023-10-01: EPS 10.21 2023-12-31: EPS 1.67 2024-03-31: EPS 1.34 2024-06-30: EPS 1.93 2024-09-29: EPS 1.11 2024-12-29: EPS 1.41 2025-03-30: EPS 4.54 2025-06-29: EPS 2.29 2025-09-28: EPS 2.12 2025-12-28: EPS 2.08 2026-03-29: EPS 2.14 0B 12.3B 24.6B $B -0.03 5.60 11.23 20222023202420252026 营收 EPS

季度申报值;EPS 已按拆股统一口径,无法校准的早期季度不展示

历史 PE(TTM)
4 年中位 19 2023-04-02: PE 30.22023-07-02: PE 322023-10-01: PE 10.32023-12-31: PE 10.62024-03-31: PE 9.52024-06-30: PE 9.92024-09-29: PE 24.22024-12-29: PE 25.92025-03-30: PE 16.32025-06-29: PE 18.42025-09-28: PE 18.62025-12-28: PE 21.82026-03-29: PE 26.1 9 21 34 20222023202420252026

PE = 季末后 47 天(财报公开日)收盘价 ÷ 当时 TTM EPS;亏损季不显示

数据截至 2026-03-29 · 来源 SEC 财报(XBRL)